Melbourne, Australia-based Caydon has started construction on its first development in the U.S. The project, 2850 Fannin Street, is the first high-rise development in the rapidly evolving Midtown neighborhood of Houston.
Designed by Ziegler Cooper Architects of Houston, the 27-story 2850 Fannin Street will cover an acre and deliver 357 units and 360-degree views. Amenities will include, among others, a large pool with swim-up bar, yoga studio, dog park and sky lounge with downtown views. Individual residences will have European-style interiors.
When complete, 2850 Fannin will be situated near the Metro Rail that runs between two of Houston’s most significant job centers. Those hubs are downtown Houston and Texas Medical Center, the world’s largest medical complex.
Caydon reports this area was chosen as the site for the firm’s first U.S. project because Midtown Houston is reminiscent of Melbourne in culture and livability. In addition, the Midtown enclave offers a very pedestrian-friendly lifestyle.
Lasting positive impact
Offering easy access to nearby freeways, 2850 Fannin is also convenient to the highly-anticipated Midtown Park and the vibrant entertainment of the quirky Montrose District.
Caydon reports its mission is to make lasting and positive impacts on neighborhoods, its developments having forged connections with the neighborhoods that surround them.
“Caydon is driven by customers and has built a strong reputation in Melbourne by consistently delivering successful projects that revitalize communities,” Caydon principal Joe Russo said. We have selected one of the most vibrant, active neighborhoods of Houston for our first U.S. residential project, offering our future residents a wide variety of dining, shopping and entertainment venues. Our vision for the tower on Fannin Street is creating an iconic landmark with modern residences that will thrive for years to come.”
Despite Hurricane Harvey’s recent wrath, the development project remains on schedule for completion. First move-ins are expected early in 2019.
(Originally published on MHN on 10 November, 2017)